Results 11 to 20 of about 139,229 (304)

Performing Subcutaneous Injections: A Literature Review [PDF]

open access: yesWorldviews on Evidence-Based Nursing, 2005
ABSTRACTBackground:Persons using daily subcutaneous injections to administer medicine perform them in different ways and thereby increase the risk of skin complications related to the injection. It is often part of nurses' role to administer medicine and educate the patient in injection technique.
Annersten, Magdalena, Willman, Ania
openaire   +5 more sources

Local Tolerance of Subcutaneous Injections

open access: yesJournal of Pharmacy and Pharmacology, 1996
Abstract Human insulin-like growth factor I (hIGF-I) has several possible clinical applications. Because subcutaneous administration of the drug can cause pain, local tolerance to injection of different formulations with or without hIGF-I has been investigated in man using isotonic saline solution as reference.
J, Fransson, A, Espander-Jansson
openaire   +3 more sources

Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease

open access: yesEurasian Journal of Medicine, 2022
The intermittent subcutaneous injection of apomorphine is highly effective in the management of motor and non-motor symptoms of Parkinson's disease. Although it has been shown that apomorphine injection can be safely used in selected cases at all stages ...
Mustafa Ceylan   +5 more
doaj   +2 more sources

Utilities associated with subcutaneous injections and intravenous infusions for treatment of patients with bone metastases

open access: yesPatient Preference and Adherence, 2013
Louis S Matza,1 Ze Cong,2 Karen Chung,2 Alison Stopeck,3 Katia Tonkin,4 Janet Brown,5 Ada Braun,2 Kate Van Brunt,6 Kelly McDaniel1 1Outcomes Research, United BioSource Corporation, Bethesda, MD, USA; 2Amgen, Inc, Thousand Oaks, CA, USA; 3Department of ...
Matza LS   +8 more
doaj   +1 more source

Best infection control practices for intradermal, subcutaneous, and intramuscular needle injections

open access: yesBulletin of the World Health Organization, 2003
OBJECTIVE: To draw up evidence-based guidelines to make injections safer. METHODS: A development group summarized evidence-based best practices for preventing injection-associated infections in resource-limited settings.
Hutin Yvan   +6 more
doaj   +1 more source

Supporting people with learning disabilities to receive subcutaneous injections

open access: yes, 2021
The average life expectancy of people with learning disabilities has increased and many of these individuals will experience long-term and potentially life-limiting conditions such as diabetes mellitus, cancer or arthritis. To manage these conditions and
Cithambaram, Kumaresan
core   +1 more source

Impact of pharmaceutical care on self-administration of outpatient low-molecular-weight heparin therapy [PDF]

open access: yes, 2014
Outpatient subcutaneous (s.c.) therapies are becoming more and more common in the treatmentof different diseases. The effectiveness of community-pharmacy-based interventions in preventingproblems that arise during s.c.
Kurt E. Hersberger   +13 more
core   +1 more source

Management and efficacy of intensified insulin therapy starting in outpatients [PDF]

open access: yes, 1989
Diabetic patients under multiple injection insulin therapy (i.e., intensified insulin therapy, IIT) usually start this treatment during hospitalization. We report here on the logistics, efficacy, and safety of IIT, started in outpatients.
Winkelmann, W.   +11 more
core   +1 more source

Placebo response with subcutaneous injections in calcitonin gene-related peptide receptor monoclonal antibody migraine preventative trials – A systematic review and meta-analysis

open access: yesCephalalgia Reports, 2022
Background: The majority of CGRP monoclonal antibodies for migraine prevention are administered subcutaneously. Therefore, we attempted to calculate the pooled placebo response with subcutaneous placebo injections in this systematic review and meta ...
Sasikanth Gorantla   +6 more
doaj   +1 more source

Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis

open access: yesCells, 2022
This study aims to evaluate safety issues of house dust mite subcutaneous immunotherapy (SCIT) among allergic rhinitis (AR) children. A retrospective cohort study was done between 2015 and 2020 to investigate the side effects of SCIT among AR children ...
Anang Endaryanto, Ricardo Adrian Nugraha
doaj   +1 more source

Home - About - Disclaimer - Privacy